Trial intelligence / Profile preview

REACT: Vector Control Strategies for Malaria

NCT03074435Phase 3Completed

Sponsor
Institut de Recherche pour le Développement
Start
Jul 2016
Primary completion
Aug 2018
Countries
2
01

Overview

Phase 3, randomised trial (5 arms), sponsored by Institut de Recherche pour le Développement. Primary endpoint: Malaria incidence density at 2 years. Started Jul 2016; status: completed.

Beyond the preview

Go deeper on NCT03074435.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03074435.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call